I Agree Alj14; ENTB Looks Solid
The company definitely had a good week. It also looks like ENTB is making a concerted effort to focus attention on stem cell therapies in the treatment of a variety of illnesses, including cancer. This particular effort is a core competency of the company, and by pushing what Ewa Carrier had to say about progress in that arena, ENTB's showing it has what it takes to thrive.
As well; if it begins to look like ENTB has the upper hand in this part of the industry, I think investors will pump the stock nicely and more capital will move into this sector. And with ENTB ready to take advantage of this fact, the prospects for a nice move look better every day.